Company profile: Renovo Concepts
1.1 - Company Overview
Company description
- Provider of Mechanical Tissue Resuscitation (MTR™), a therapeutic modality using controlled vacuum to enhance microcirculation, improve cell survival, and reduce injury volume and secondary pathologies. Offerings include the Sub-atmospheric Pressure Pump™ (SaPP™) and a Gen 1 MTR™ brain application targeting traumatic brain injuries to decrease injury severity and improve recovery.
Products and services
- Mechanical Tissue Resuscitation (MTR™): A controlled-vacuum therapeutic modality that treats injuries by enhancing cell survival and reducing injury volume, delivering tissue resuscitation through sub-atmospheric pressure application
- Gen 1 MTR™ Brain application: A first-generation brain-targeted therapy that aims to decrease injury severity and improve recovery outcomes by improving microcirculation and mitigating secondary pathologies in traumatic brain injuries
- Sub-atmospheric Pressure Pump™ (SaPP™): A sub-atmospheric device that applies controlled vacuum pressure to injured areas, promoting tissue resuscitation within the MTR paradigm by supporting cell survival and reduced injury volume
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Renovo Concepts
Acticor Biotech
HQ: France
Website
- Description: Provider of biopharmaceutical development of glenzocimab, a humanized monoclonal antibody fragment targeting platelet GPVI with antithrombotic properties without increasing bleeding risk, for the acute phase of ischemic stroke. Runs clinical trials: ACTISAVE, ACTIMIS, and GREEN in stroke, LIBERATE in myocardial infarction, and GARDEN in SARS-CoV-2-related ARDS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acticor Biotech company profile →
Envoy Therapeutics
HQ: United States
Website
- Description: Provider of drug discovery focused on novel drugs for neurological and psychiatric diseases, using bacTRAP technology to identify proteins in vivo produced by specific cell types without isolating those cells, aiming for superior efficacy and fewer side effects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Envoy Therapeutics company profile →
Oryzon Genomics
HQ: Spain
Website
- Description: Provider of epigenetics-based therapeutics for cancer and CNS disorders, leveraging an epigenetic platform to identify biomarkers and targets and develop personalized therapies. Portfolio includes iadademstat (ORY-1001), an oral LSD1 inhibitor for leukemia and small cell lung cancer; vafidemstat (ORY-2001) for CNS disorders; ORY-4001, a selective HDAC6 inhibitor; and ORY-3001 for non-oncological diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oryzon Genomics company profile →
Acumen Pharmaceuticals
HQ: United States
Website
- Description: Provider of targeted therapies in development for Alzheimer's disease and related neurodegenerative diseases, including ACU193, a monoclonal antibody targeting toxic soluble amyloid-beta oligomers (AβOs) for early Alzheimer's, and the INTERCEPT-AD Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics in patients with mild cognitive impairment or mild dementia due to Alzheimer's.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acumen Pharmaceuticals company profile →
ADx Neurosciences
HQ: Belgium
Website
- Description: Provider of proprietary biomarker assays and antibody solutions for neurodegenerative diseases, enabling early detection of Alzheimer’s, Parkinson’s and traumatic brain injury. Delivers custom and monoclonal antibodies (Amyloid-beta, Tau, Synuclein), pharma and IVD solutions from antibody to qualified assay and automated kits, and co-develops commercial immunoassays for clinical and drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ADx Neurosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Renovo Concepts
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Renovo Concepts
2.2 - Growth funds investing in similar companies to Renovo Concepts
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Renovo Concepts
4.2 - Public trading comparable groups for Renovo Concepts
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →